The Impact of AC and AC-T Chemotherapy’s Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study

References

• YusufA, SairiI, HadiA, MahamoodZ, AhmadZ. Quality of life in malay and chinese women newly diagnosed with breast cancer in kelantan, Malaysia. Asian Pacific J Cancer Prev. 2013;14(1):435–440. doi:10.7314/APJCP.2013.14.1.435
   Google Scholar
• LeeCK, StocklerMR, CoatesAS, GebskiV, LordSJ, SimesRJ. Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. Br J Cancer. 2010;102(9):1341–1347. doi:10.1038/sj.bjc.660564920389302
   PubMed Web of Science ®Google Scholar
• ParkJ, JungYS, JungY, BaeSH. The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients. Support Care Cancer. 2018.
   Web of Science ®Google Scholar
• TrögerW, JezdićS, ŽdraleZ, TišmaN, HamreHJ. Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone. Breast Cancer Basic Clin Res. 2009;3:35–45. doi:10.4137/BCBCR.S2905
   PubMedGoogle Scholar
• FerreiraAR, DiMA, PistilliB, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019:1–12. doi: 10.1093/annonc/mdz298.
   Web of Science ®Google Scholar
• LipscombJ, ReeveBB, ClauserSB, et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol. 2007;25(32):5133–5140. doi:10.1200/JCO.2007.12.464417991933
   PubMed Web of Science ®Google Scholar
• CalvertM, BlazebyJ, AltmanDG, RevickiDA, MoherD, BrundageMD. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–822. doi:10.1001/jama.2013.87923443445
   PubMed Web of Science ®Google Scholar
• ChenQ, LiS, WangM, LiuL. Health-related quality of life among women breast cancer patients in Eastern China. Biomed Res Int. 2018. doi:10.1155/2018/1452635.
   Web of Science ®Google Scholar
• CortesJ, HudgensS, TwelvesC, et al. Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized Phase 3 trial. Breast Cancer Res Treat. 2015;154:509–520. doi:10.1007/s10549-015-3633-726567010
   PubMed Web of Science ®Google Scholar
• CardosoF, DiLA, LohrischC, et al. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades ?Ann Oncol. 2002;13:197–207. doi:10.1093/annonc/mdf10111885995
   PubMed Web of Science ®Google Scholar
• GunnarsB, NygrenP, GlimeliusB, GunnarsB, NygrenP, GlimeliusB. Assessment of quality of life during chemotherapy. Acta Oncol. 2001;40(2–3):175–184. doi:10.1080/0284186012132511441930
   PubMed Web of Science ®Google Scholar
• AlzabaideyFJ. Quality of life assessment for patients with breast cancer receiving adjuvant therapy. J Cancer Sci Ther. 2012;4(3):51–55. doi:10.4172/1948-5956.1000110
   Google Scholar
• ElFS, AbdaN, BendahhouK, et al. The european organization for research and treatment of cancer quality of life questionnaire-BR 23 breast cancer-specific quality of life questionnaire: psychometric properties in a Moroccan sample of breast cancer patients. BMC Res Notes. 2014;7:53. doi:10.1186/1756-0500-7-5324447401
   PubMedGoogle Scholar
• LôboSA, FernandesAF. Quality of life in women with breast cancer undergoing chemotherapy. Acta Paul Enferm. 2014;27(6):554–559. doi:10.1590/1982-0194201400090
   Web of Science ®Google Scholar
• KnobfMT. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. Oncologist. 2006;11(2):96–110. doi:10.1634/theoncologist.11-2-9616476831
   PubMed Web of Science ®Google Scholar
• QuintenC, KenisC, HamakerM, et al. The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥ 70 with early stage invasive breast cancer. J Geriatr Oncol. 2018;9(2):152–162. doi:10.1016/j.jgo.2017.10.00129167064
   PubMed Web of Science ®Google Scholar
• Prieto-callejeroB, RiveraF. Influence of the sense of coherence, the doctor – patient relationship, optimism and non-haematological adverse reactions on health-related quality of life in patients with breast cancer. J Clin Med. 2019;8:2043. doi:10.3390/jcm8122043
   Web of Science ®Google Scholar
• WagnerLI, ZhaoF, GossPE, et al. Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03). Breast Cancer Res Treat. 2018;169(3):537–548. doi:10.1007/s10549-018-4713-229455298
   PubMed Web of Science ®Google Scholar
• MirR, SinghVP. Breast cancer in young women and its impact on reproductive function. Apollo Med. 2009;6(3):200–208. doi:10.1016/S0976-0016(11)60528-0
   Google Scholar
• VermaS, ShaughnessyJO, BurrisHA, et al. Health ‑ related quality of life of postmenopausal women with hormone receptor ‑ positive, human epidermal growth factor receptor 2 - negative advanced breast cancer treated with ribociclib + letrozole: results from Monaleesa - 2. Breast Cancer Res Treat. 2018;170:535–545. doi:10.1007/s10549-018-4769-z29654415
   PubMed Web of Science ®Google Scholar
• FrieseCR, HarrisonJM, JanzNK, JagsiR. Treatment-associated toxicities reported by patients with early-stage invasive breast cancer. Cancer. 2017;123:1925–1934. doi:10.1002/cncr.3054728117882
   PubMed Web of Science ®Google Scholar
• GroenvoldM. Health-related quality of life in early breast cancer. Dan Med Bull. 2010;57:B4184.20816024
   PubMedGoogle Scholar
• GadisaDA, GebremariamET, AliGY. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia. Health Qual Life Outcomes. 2019;17(182):1–8. doi:10.1186/s12955-019-1257-z30606205
   PubMed Web of Science ®Google Scholar
• GadisaDA, AssefaM, TeferaGM, YimerG. Patterns of anthracycline-based chemotherapy-induced adverse drug reactions and their impact on relative dose intensity among women with breast cancer in ethiopia: a prospective observational study. J Oncol. 2020;2020:1–12. doi:10.1155/2020/2636514
   Web of Science ®Google Scholar
• GadisaDA, AssefaM, WangS, YimerG. Toxicity profile of doxorubicin- cyclophosphamide and doxorubicin- cyclophosphamide followed by paclitaxel regimen and its associated factors among women with breast cancer in ethiopia: a prospective cohort study. J Oncol Pharm Pract. 2020;26(8):1912–1920. doi:10.1177/107815522090765832122234
   PubMed Web of Science ®Google Scholar
• U.S. Department of health and human services. common terminology criteria for adverse events v4.0 (CTCAE); 2010 v4.03:1–194. Available from:https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed 122, 2021.
   Google Scholar
• BaschE, ReeveBB, MitchellSA, et al. Development of the national cancer institute ’ s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244. doi:10.1093/jnci/dju24425265940
   PubMedGoogle Scholar
• AaronsonN, AhmedzaiS, BergmanB, et al. The European organisation for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi:10.1093/jnci/85.5.3658433390
   PubMed Web of Science ®Google Scholar
• FayersP, AaronsonN, BjordalK, GroenvoldM, CurranD, BottomleyAOn Behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual (3rd Edition). third. Brussels; 2001.
   Google Scholar
• ParkYH, JungKH, ImSA, et al. Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02). Breast Cancer Res Treat. 2015;152(1):77–85. doi:10.1007/s10549-015-3450-z26033708
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of helsinki: ethical principles for medical research involving human subjects. 2008; 1–5. doi:10.1093/acprof:oso/9780199241323.003.0025
   Google Scholar
• OsobaD, SlamonDJ, BurchmoreM, MurphyM. Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer. J Clin Oncol. 2002;20:3106–3113. doi:10.1200/JCO.2002.03.09012118024
   PubMed Web of Science ®Google Scholar
• BrowallM, AhlbergK, KarlssonP, DanielsonE, PerssonL, Gaston-johanssonF. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs. 2008;12:180–189. doi:10.1016/j.ejon.2008.01.00518343197
   PubMed Web of Science ®Google Scholar
• HatamN, AhmadlooN, DaliriAAK, BastaniP, AskarianM. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide). Arch Gynecol Obs. 2011;284:215–220. doi:10.1007/s00404-010-1609-8
   Web of Science ®Google Scholar
• PerroudHA, AlasinoCM, RicoMJ, et al. Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy. Futur Oncol. 2016;12:1233–1242. doi:10.2217/fon-2016-0075
   PubMed Web of Science ®Google Scholar
• ChaganiP, ParpioY, GulR, JabbarAA. Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakistan. Asia Pac J Oncol Nurs. 2017;4(2):140–146. doi:10.4103/2347-5625.20449928503647
   PubMed Web of Science ®Google Scholar
• PerryS, KowalskiTL, ChangC. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes. 2007;5:24. doi:10.1186/1477-7525-5-2417474993
   PubMed Web of Science ®Google Scholar
• HallE, CameronD, WatersR, Barrett-leeP, EllisP, RussellS. Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/00. Eur J Cancer. 2014;50(14):2375–2389. doi:10.1016/j.ejca.2014.06.00725065293
   PubMed Web of Science ®Google Scholar
• OsobaD, RodriguesG, MylesJ, ZeeB, PaterJ. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–144. doi:10.1200/JCO.1998.16.1.1399440735
   PubMed Web of Science ®Google Scholar
• DzingiraiB, WarivaRN, ManyauP, MatyangaC. Health related quality of life among breast cancer patients undergoing adjuvant chemotherapy at a tertiary health facility: a cross sectional study. Value Heal. 2020;23(May):S28. doi:10.1016/j.jval.2020.04.1539
   Google Scholar
• LimaEDNS, FerreiraIB, LajoloPP, PaivaCE, MaiaYCDP, PenaGDG. Health-related quality of life became worse in short-term during treatment in head and neck cancer patients: a prospective study. Health Qual Life Outcomes. 2020;18(307).
   Google Scholar
• AberarawR, BokaA, TeshomeR, YeshambelA. Social networks and quality of life among female breast cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia 2019. BMC Womens Health. 2020;20:50. doi:10.1186/s12905-020-00908-832160874
   PubMed Web of Science ®Google Scholar
• HorwitzEM, HanlonAL, PinoverWH, AndersonPR, HanksGE. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: A prospective study. Cancer. 2001;92:1288–1298. doi:10.1002/1097-0142(20010901)92:5<1288::AID-CNCR1450>3.0.CO;2-E11571745
   PubMed Web of Science ®Google Scholar
• ChoO. Changes in fatigue, psychological distress, and quality of life after chemotherapy in women with breast cancer. Cancer Nurs. 2020;43(1):54–60. doi:10.1097/NCC.0000000000000689
   Web of Science ®Google Scholar
• KobotoDD, DeribeB, GebretsadikA, et al. Quality of life among breast cancer patients attending Hawassa University comprehensive specialized hospital cancer treatment center. Breast Cancer Targets Ther. 2020;12:87–95. doi:10.2147/BCTT.S252030
   Web of Science ®Google Scholar
• HoPJ, GernaatSAM, HartmanM, VerkooijenHM. Health-related quality of life in Asian patients with breast cancer: A systematic review. BMJ Open. 2018;8:4. doi:10.1136/bmjopen-2017-020512
   Web of Science ®Google Scholar
• HassenAM, TayeG, GizawM, HussienFM. Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized. PLoS One. 2019;1–13. doi:10.1371/journal.pone.0222629
   Web of Science ®Google Scholar
• WondieY, HinzA. Quality of life among Ethiopian cancer patients. Support Care Cancer. 2020;28(11):5469–5478. doi:10.1007/s00520-020-05398-w32170441
   PubMed Web of Science ®Google Scholar
• SilvaC, MachadoP. Prevalence of symptoms and quality of life of cancer patients. Rev Bras Enferm. 2020;73(2):e20180287. doi:10.1590/0034-7167-2018-028732162649
   PubMed Web of Science ®Google Scholar
• AbegazTM, AyeleAA, GebresillassieBM. Health related quality of life of cancer patients in Ethiopia. J Oncol. 2018;2018:1–8. doi:10.1155/2018/1467595
   Web of Science ®Google Scholar
• FetainiM, HawariA, KakiF, UjaimiR. Impact of breast cancer treatments on body image and quality of life in survivors. Int J Med Dev Ctries. 2020;4(3):635–644.
   Google Scholar
• LandSR, KopecJA, YothersG, et al. Health-related quality of life in axillary node-negative, estrogen receptor- negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the national surgical adjuvant breast and bowel project B-23 *. Breast Cancer Res Treat. 2004;86(2):153–164. doi:10.1023/B:BREA.0000032983.87966.4e15319567
   PubMed Web of Science ®Google Scholar
• MohsinS, RehmanMU, AzamN, MashhadiSF. Comparison of quality of life of cancer patients undergoing chemotherapy in a tertiary care hospital, Rawalpindi. Pak Armed Forces Med J. 2016;66(1):83–87.
   Google Scholar
• MegariK. Quality of life in chronic disease patients. Heal Psychol Res. 2013;1:17–20. doi:10.1016/j.jpainsymman.2020.11.029
   Web of Science ®Google Scholar
• Prieto-callejeroB, RiveraF, Fagundo-riveraJ, RomeroA, Ruiz-frutosC. Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine. 2020;99:33(e21695. doi:10.1097/MD.0000000000021695
   Web of Science ®Google Scholar
• MartınM, LluchA, Seguı´MA, et al. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Ann Oncol. 2006;17:1205–1212. doi:10.1093/annonc/mdl13516766587
   PubMed Web of Science ®Google Scholar
• FarthmannJ, VeitJ, RautenbergB, StickelerE. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life female sexual function index questionnaire. Support Care Cancer. 2016;24:2603–2609. doi:10.1007/s00520-015-3073-226728760
   PubMed Web of Science ®Google Scholar
• TiezziMFBDM, AndradeJMD, RomaAPMS, et al. Quality of life in women with breast cancer treated with or without chemotherapy. Cancer Nurs. 2017;40(2):108–116. doi:10.1097/NCC.000000000000037027070221
   PubMed Web of Science ®Google Scholar
• ElHR, AbbasLA, NerichV, AnotaA. Factors associated with health-related quality of life in women with breast cancer in the middle east: A systematic review. Cancers. 2020;12:696. doi:10.3390/cancers12030696
   Web of Science ®Google Scholar
• Macquart-MoulinGV, ViensP, GenreD, et al. Concomitant chemoradiotherapy for patients with. Cancer. 1999;85:2190–2199. doi:10.1002/(SICI)1097-0142(19990515)85:10<2190::AID-CNCR13>3.0.CO;2-P10326697
   PubMed Web of Science ®Google Scholar
• WitloxL, SchagenSB, DeRMB, et al. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. BMJ Open. 2019;9:e028117. doi:10.1136/bmjopen-2018-028117
   PubMed Web of Science ®Google Scholar
• DeJN, CandelMJJM, SchoutenHC, Abu-saadHH, CourtensAM. Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol. 2004;15:896–905. doi:10.1093/annonc/mdh22915151946
   PubMed Web of Science ®Google Scholar
• ArndtV, StegmaierC, ZieglerH, BrennerH. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer. 2006;107:2496–2503. doi:10.1002/cncr.2227417048250
   PubMed Web of Science ®Google Scholar
• JanzNK, MujahidM, ChungLK, et al. Symptom experience and quality of life of women following breast cancer treatment. J Women’s Heal. 2007;16(9):1348–1361. doi:10.1089/jwh.2006.0255
   PubMed Web of Science ®Google Scholar
• HovanAJ, WilliamsPM, Stevenson-mooreP, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010;18:1081–1087. doi:10.1007/s00520-010-0902-120495984
   PubMed Web of Science ®Google Scholar
• CurtGA, BreitbartW, CellaD, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5:353–360. doi:10.1634/theoncologist.5-5-35311040270
   PubMedGoogle Scholar
• Álvarez-bustosA, CantosB, MaximianoC, HidalgoF, ValenzuelaPL. Concurrent exercise interventions in breast cancer survivors with cancer-related fatigue authors. Int J Sport Med. 2020. doi:10.1055/a-1147-1513
   Web of Science ®Google Scholar
• EhlersDK, DuboisK, SalernoEA. The effects of exercise on cancer-related fatigue in breast cancer patients during primary treatment: a meta-analysis and systematic review. Expert Rev Anticancer Ther. 2020;20:865–877. doi:10.1080/14737140.2020.181302832842816
   PubMed Web of Science ®Google Scholar
• Mokhatri-HesariP, MontazeriA. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18:338. doi:10.1186/s12955-020-01591-x33046106
   PubMed Web of Science ®Google Scholar
• PonticelliRE, ClariRM, FrigerioS, et al. Dysgeusia and health-related quality of life of cancer patients receiving chemotherapy: A cross- - sectional study. Eur J Cancer Care. 2016:1–7. doi: 10.1111/ecc.12633.
   Web of Science ®Google Scholar
• DendaY, NiikuraN, SatohS, KozueK, MayakoY, ToruT. Taste alterations in patients with breast cancer following chemotherapy: a cohort study. Breast Cancer. 2020;27:954–962. doi:10.1007/s12282-020-01089-w32301097
   PubMed Web of Science ®Google Scholar
• KiH, UmbergerW, AktasA, et al. The effect of constipation and pain on the psychoneurological symptoms and performance in advanced breast cancer women. Prensa Med Argent. 2020;106(3):206. doi:10.47275/0032-745X-206
   Google Scholar
• OnedaE, MeriggiF, ZanottiL, et al. Innovative approach for the prevention of chemotherapy-induced peripheral neuropathy in cancer patients: a pilot study with the hilotherm device, the poliambulanza hospital experience. Integr Cancer Ther. 2020;19:1–11. doi:10.1177/1534735420943287
   Web of Science ®Google Scholar
• CameronD, MordenJP, CanneyP, et al. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label. Lancet Oncol. 2017;18:1–17. doi:10.1016/S1470-2045(17)30404-728049567
   PubMed Web of Science ®Google Scholar
• Al-BatranSE, HozaeelW, TauchertFK, et al. The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax). Ann Oncol. 2015;26:1244–1248. doi:10.1093/annonc/mdv12925755108
   PubMed Web of Science ®Google Scholar
• ZanvilleNR, NudelmanKNH, SmithDJ, et al. Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment. Support Care Cancer. 2016;24:4779–4789. doi:10.1007/s00520-016-3329-527470258
   PubMed Web of Science ®Google Scholar
• WaglandR, RichardsonA, EwingsS, et al. Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey. Support Care Cancer. 2016;24:4901–4911. doi:10.1007/s00520-016-3346-427465050
   PubMed Web of Science ®Google Scholar
• LeinertE, SingerS, JanniW, et al. The impact of age on quality of life in breast cancer patients receiving adjuvant chemotherapy: a comparative analysis from the prospective. Clin Breast Cancer. 2017;17(2):100–106. doi:10.1016/j.clbc.2016.10.00827884722
   PubMed Web of Science ®Google Scholar
• LavdanitiM, OwensDA, LiamopoulouP, MarmaraK. Factors influencing quality of life in breast cancer patients six months after the completion of chemotherapy. Diseases. 2019;7(26):1–16. doi:10.3390/diseases7010026
   Web of Science ®Google Scholar
• CarayolM, NinotG, SenesseP, et al. Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the “ APAD1 ” randomized controlled trial. BMC Cancer. 2019;19:737. doi:10.1186/s12885-019-5896-631345179
   PubMed Web of Science ®Google Scholar
• GebruersN, CamberlinM, TheunissenF, et al. The effect of training interventions on physical performance, quality of life, and fatigue in patients receiving breast cancer treatment: a systematic review. Support Care Cancer. 2018;27:109–122. doi:10.1007/s00520-018-4490-930302542
   PubMed Web of Science ®Google Scholar
• Ruiz-vozmedianoJ, LöhnchenS, JuradoL, et al. Influence of a multidisciplinary program of diet, exercise, and mindfulness on the quality of life of stage IIA-IIB breast cancer survivors. Integr Cancer Ther. 2020;19:1–11. doi:10.1177/1534735420924757
   Web of Science ®Google Scholar